Hem › Övervikt › Florida › Miami
Kliniska studier för Övervikt i Miami, FL
23 studier för Övervikt söker deltagare vid platser i och runt Miami (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
RekryterarFas 1
- Clinical Pharmacology of Miami, Miami
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekryterarFas 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RekryterarFas 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekryterarFas 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekryterarFas 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
RekryterarFas 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekryterarFas 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RekryterarFas 3
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RekryterarFas 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekryterarFas 3
- Finlay Medical Research, Miami
- Suncoast Research Group LLC, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekryterarFas 3
- BioMed Research & Medical Center, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekryterarFas 2
- New Horizon Research Center, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RekryterarFas 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RekryterarFas 3Friska volontärer välkomna
- ACCOMPLISH-2 Research Site, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekryterarFas 2
- New Horizon Research Center, Miami
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RekryterarFas 3
- Kailera Clinical Site, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekryterarFas 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekryterarFas 3
- Optimus U Corporation, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekryterarFas 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RekryterarFas 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
RekryterarObservationsstudieFriska volontärer välkomna
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
RekryterarObservationsstudieFriska volontärer välkomna
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
RekryterarObservationsstudieFriska volontärer välkomna
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Övervikt-studier i andra städer
- San Antonio, TX34 studier
- Houston, TX33 studier
- Chicago, IL28 studier
- Orlando, FL27 studier
- Las Vegas, NV23 studier
- Atlanta, GA20 studier
- Dallas, TX20 studier
- New York City, NY19 studier
- Jacksonville, FL19 studier
- Washington, DC19 studier
- Austin, TX18 studier
- Baltimore, MD17 studier
Andra studier i Miami
- Bröstcancer42 studier
- Cancer (alla typer)36 studier
- Icke-småcellig lungcancer31 studier
- Prostatacancer27 studier
- Övervikt27 studier
- Akut myeloid leukemi24 studier
- Metastaserande cancer24 studier
- Äggstockscancer23 studier
- Multipelt myelom21 studier
- Ulcerös kolit21 studier
- Alzheimers sjukdom20 studier
- Lungcancer20 studier
Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.